Vonoprazan Acetate

醋酸沃诺拉赞

Report date: 2025/08/25 10:53:02

Base Information

Drug NameVonoprazan Acetate
Drug Alias Name沃诺拉赞醋酸盐醋酸沃诺拉赞（2.2类改良型）
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium-transporting ATPase inhibitors
TargetsPotassium-transporting ATPase
Therapy Area/IndicationsHelicobacter pylori infectionPeptic Ulcer HemorrhageGastrointestinal Hemorrhage
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesNanjing Ke Feiping Medical Technology Co LtdXizang Carefree Pharmaceutical Co LtdNanjing Shenzhou Jiamei Pharmaceutical Co Ltd +[4] 
China Registration ClassN/A

Develop Information

Active CompaniesTakeda Pharmaceutical Co LtdXizang Carefree Pharmaceutical Co LtdJiangsu Carephar Pharmaceutical Co Ltd +[5] 
Inactive CompaniesN/A
Active IndicationsHelicobacter pylori infectionPeptic Ulcer HemorrhageGastrointestinal Hemorrhage
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A